Levopropoxyphene napsilate or levopropoxyphene napsylate
- Level
- Commodity
- Parent
- 51162600
- Below
- 0
- Links · KBLI
- 9
Definition
UNSPSC 51162631This classification denotes an antitussive agent with the molecular formula C22H29NO2.C10H8O3S.H2O, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier KK9590R73S, chemically known as benzeneethanol, .alpha.-(2-(dimethylamino)-1-methylethyl)-.alpha.-phenyl-, propanoate (ester), (r-(r*,s*))-, compd. with 2-naphthalenesulfonic acid (1:1), monohydrate, but more generally known as levopropoxyphene napsilate, which bears US NIH Compound Identifier 64736. European Medicines Agency schedules levopropoxyphene napsilate or its base in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08486MIG. Most nations, for tariff purposes, schedule levopropoxyphene napsilate under HS 29221980. SMILES: CCC(=O)O[C@@](CC1CCCCC1)(C2CCCCC2)[C@@H](C)CN(C)C.C1CCC2CC(CCC2C1)S(=O)(=O)O.O.
Same parent
Under 51162600 · 55Activities that produce or sell this
KBLI · 9Inherited from family 51160000.
Warning
The links were generated with a large language model (Gemini 3.5 Flash), matching UNSPSC at the family level to KBLI at the kelompok level. Some of them maybe are wrong, so check any link you intend to rely on.